AVII Financial Facts

See Full Income Statement

Total Current Assets: 176.59M
Total Current Liabilities: 103.66M
See Full Balance Sheet

Earnings History for AVI Biopharma, Inc. (AVII)

  |   Expand Research on AVII
Next EPS Date 8/3/12 *Est. EPS Growth Rate -750.0% *Last Qtr.
Average EPS % Beat Rate +40.5% Revenue Growth Rate -26.8% *Last Qtr.
Average % Move 1-Wk after EPS -1.6%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/10/12 Q112 -$0.13-$0.07 -$0.06$11.2M$11.05M N/A / N/A = 0% Details
3/10/11 Q410 -$0.07-$0.07 $0.00$15.5M$11.65M N/A / N/A = -65.1% Details
11/3/11 Q311 -$0.03-$0.06 +$0.03N/A$13.88M N/A / N/A = 0% Details
3/1/12 Q411 -$0.01-$0.06 +$0.05$13.6M$11.03M N/A / N/A = -36.5% Details
8/4/11 Q211 $0.01-$0.07 +$0.08$11.6M$13.67M N/A / N/A = -47.2% Details
5/5/11 Q111 $0.02-$0.03 +$0.05$15.3M$13.55M N/A / N/A = -60.7% Details
Like AVII Earnings? Also take a look at SRPT, SVA, HEB, BCRX

AVII Earnings News